[
  {
    "ts": null,
    "headline": "Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals",
    "summary": "Novavax sees Sanofi deal as path forward for company into profitability.",
    "url": "https://finnhub.io/api/news?id=ea6d77ddca71c020997eacc8875d46b4708e709e38e344f798a4a2bc55ea9464",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731440590,
      "headline": "Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals",
      "id": 131310041,
      "image": "https://s.yimg.com/ny/api/res/1.2/L_paiH5PSqCa4kA0g_2cCQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05MDA-/https://s.yimg.com/os/creatr-uploaded-images/2021-06/1f18aa40-cd50-11eb-976f-18ecd0587655",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Novavax sees Sanofi deal as path forward for company into profitability.",
      "url": "https://finnhub.io/api/news?id=ea6d77ddca71c020997eacc8875d46b4708e709e38e344f798a4a2bc55ea9464"
    }
  },
  {
    "ts": null,
    "headline": "FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine",
    "summary": "The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.",
    "url": "https://finnhub.io/api/news?id=742236924da89cffc2e0eaee5246ed46241dde60dde7246e00d93cde2de9377a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731433977,
      "headline": "FDA clears Novavax to resume trials of Covid-19 and flu combo vaccine",
      "id": 131309604,
      "image": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/11/shutterstock_2517614377-e1731427317388.jpg",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The FDA agreed for Novavax to continue trials of its vaccine combo after addressing a serious adverse event that paused trials.",
      "url": "https://finnhub.io/api/news?id=742236924da89cffc2e0eaee5246ed46241dde60dde7246e00d93cde2de9377a"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Inc. stock outperforms competitors on strong trading day",
    "summary": "Moderna Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=554094fa4ec984716364f9dd0ede0aec420b8bf2ab49ef2db49f9e48d92214fc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731429120,
      "headline": "Moderna Inc. stock outperforms competitors on strong trading day",
      "id": 131432200,
      "image": "",
      "related": "MRNA",
      "source": "MarketWatch",
      "summary": "Moderna Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=554094fa4ec984716364f9dd0ede0aec420b8bf2ab49ef2db49f9e48d92214fc"
    }
  },
  {
    "ts": null,
    "headline": "Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year",
    "summary": "CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one large employer in BioSpace's 2025 Best Places to Work report based on the Company's reputation and commitment to innovation. ...",
    "url": "https://finnhub.io/api/news?id=53c23ca4690714117111ccf3dabf20b33ca615ee8c8a0e8f4331209bfe20c466",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731417300,
      "headline": "Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year",
      "id": 131309605,
      "image": "https://media.zenfs.com/en/accesswire.ca/2233b456baebcb9b5dcb57d6eaa868ac",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one large employer in BioSpace's 2025 Best Places to Work report based on the Company's reputation and commitment to innovation. ...",
      "url": "https://finnhub.io/api/news?id=53c23ca4690714117111ccf3dabf20b33ca615ee8c8a0e8f4331209bfe20c466"
    }
  },
  {
    "ts": null,
    "headline": "Moderna: ranked among the 'Best Places to Work' by BioSpace",
    "summary": "Moderna has been ranked 1st in BioSpace's 'Best Places to Work 2025' ranking, thanks to its reputation and commitment to innovation. Stéphane Bancel, CEO of Moderna, expresses his pride at being...",
    "url": "https://finnhub.io/api/news?id=797f733ceffd2300de0a301f490271557e9c832a0a958dffacf3e4d82f97a81d",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731409462,
      "headline": "Moderna: ranked among the 'Best Places to Work' by BioSpace",
      "id": 131306085,
      "image": "",
      "related": "MRNA",
      "source": "Finnhub",
      "summary": "Moderna has been ranked 1st in BioSpace's 'Best Places to Work 2025' ranking, thanks to its reputation and commitment to innovation. Stéphane Bancel, CEO of Moderna, expresses his pride at being...",
      "url": "https://finnhub.io/api/news?id=797f733ceffd2300de0a301f490271557e9c832a0a958dffacf3e4d82f97a81d"
    }
  }
]